BioGaia AB (publ) (BIOGY)
Company Description
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide.
It operates through three segments: Pediatrics, Adult Health, and Other.
The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.
The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product.
The Other segment provides packaging solutions.
The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density.
It offers its products under the BioGaia brand name.
BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Country | SE |
IPO Date | Jan 8, 2021 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 225 |
CEO | Theresa P. Agnew |
Contact Details
Address: Kungsbroplan 3 Stockholm, SE | |
Website | https://www.biogaia.com |
Stock Details
Ticker Symbol | BIOGY |
Exchange | PNK |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001572957 |
CUSIP Number | 09072J102 |
ISIN Number | US09072J1025 |
Employer ID | 00-0000000 |
SIC Code |
Key Executives
Name | Position |
---|---|
Theresa P. Agnew | Chief Executive Officer & President |
Alexander Kotsinas M.Sc. (Eng.). | Executive Vice President & Chief Financial Officer |
Caroline Mofors | Chief Legal Officer |
Linda Hagglund | Chief Marketing Officer |
Ludvig Milesson | Chief Operating Officer |
Angelika Kjelldorff | Chief HR Officer |
Gianfranco Grompone | Chief Scientific Officer and Vice President of Research & Development |
Jonathan Gromark | Sustainability Manager |
Peter Rothschild M.Sc. Econ., MBA | Founder & Chairman |
Sebastian Heimfors | Vice President & Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 26, 2022 | F-6 POS | Filing |
May 23, 2022 | F-6 POS | Filing |
May 18, 2022 | F-6 POS | Filing |
Apr 01, 2021 | F-6EF | Filing |
Jun 30, 2017 | F-6EF | Filing |
Mar 27, 2013 | F-6EF | Filing |